Search research articles
Contact Us
Filters
Showing results (1451-1460 of 1,545) with videos related to
Page
of 155
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
May 19, 2022
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
Clinical and Molecular Hepatology
|
October 20, 2022
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, et al.
Frontiers in Medicine
|
October 17, 2022
A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
Clarissa Elysia Fu, Cheng Han Ng, Nicholas W S Chew, et al.
Clinical and Molecular Hepatology
|
March 2, 2022
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates
Wen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
The American Journal of Surgical Pathology
|
October 2, 2025
PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 Fusion
Carina A Dehner, Jorge Torres-Mora, Judith Jebastin Thangaiah, et al.
Digestive Diseases and Sciences
|
November 16, 2023
Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis
Zhen Yu Wong, Jia Hong Koh, Mark Muthiah, et al.
European Journal of Preventive Cardiology
|
May 15, 2023
Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes Mellitus: an Umbrella review of systematic reviews
Clyve Yu Leon Yaow, Bryan Chong, Yip Han Chin, et al.
Rheumatology (Oxford, England)
|
August 12, 2025
Non-negligible risk of HBV reactivation among rheumatoid arthritis patients receiving JAK inhibitors: bridging the evidence gap
Ting-Yuan Lan, Tai-Ju Lee, Ting-Wei Chang, et al.
Metabolism: Clinical and Experimental
|
June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Page
of 155
Search research articles
Search
Showing results (1451-1460 of 1,545) with videos related to
Sort By:
Page
of 155
The Journal of Clinical Endocrinology and Metabolism
|
May 19, 2022
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
Clinical and Molecular Hepatology
|
October 20, 2022
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, et al.
Frontiers in Medicine
|
October 17, 2022
A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
Clarissa Elysia Fu, Cheng Han Ng, Nicholas W S Chew, et al.
Clinical and Molecular Hepatology
|
March 2, 2022
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates
Wen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
The American Journal of Surgical Pathology
|
October 2, 2025
PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 Fusion
Carina A Dehner, Jorge Torres-Mora, Judith Jebastin Thangaiah, et al.
Digestive Diseases and Sciences
|
November 16, 2023
Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis
Zhen Yu Wong, Jia Hong Koh, Mark Muthiah, et al.
European Journal of Preventive Cardiology
|
May 15, 2023
Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes Mellitus: an Umbrella review of systematic reviews
Clyve Yu Leon Yaow, Bryan Chong, Yip Han Chin, et al.
Rheumatology (Oxford, England)
|
August 12, 2025
Non-negligible risk of HBV reactivation among rheumatoid arthritis patients receiving JAK inhibitors: bridging the evidence gap
Ting-Yuan Lan, Tai-Ju Lee, Ting-Wei Chang, et al.
Metabolism: Clinical and Experimental
|
June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Page
of 155